selected publications
-
HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.
Cancer cell.
2018
Academic Article
GET IT
Times cited: 87 -
LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML.
Blood.
2018
Academic Article
GET IT
Times cited: 86 -
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches.
Molecular cell.
2015
Information Resource
GET IT
Times cited: 41